The Valley Desk

NCT00241501 · Interventional trial

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

Overall registry status Completed

Phase 3

Conditions Gastroesophageal Reflux Disease (GERD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov